Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas of the Anogenital Tract and of the Head-neck Region for the Development of Shared Therapeutic Strategies

NCT06236464 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.

NCT NCT06236464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06236464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas of the Anogenital Tract and of the Head-neck Region for the Development of Shared Therapeutic Strategies
Lead sponsor
National Cancer Institute, Naples
Phase
Observational
Overall status
Recruiting
Start date
September 25, 2023
Completion date
March 31, 2026
Enrollment
170 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of the anus, squamous cell carcinoma of the head and neck